glp-1 brain inflammation Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease GLP-1 Medications: A Game Changer

The ethanol (ulcer) group had a significantly lower gastric pH than the control group

Early observational reports suggest that people on GLP-1 therapy who also practice moderate fasting (e.g., 1416 hour daily fasts) experience more stable appetite control throughout the day and fewer breakthrough hunger episodes

Serena Williams opens up about GLP-1 weight loss in new Ro ad August 21, 2025 10:43 AM EDT Featured Stories Grading 6 purpose marketing adsexpert weighs in on Claude, Polaroid and more Purpose marketing expert Thomas Kolster on what works, and does not work, on recent purpose ads.

A thoughtful diet plan while on semaglutide or tirzepatide diet plan makes a substantial difference in side effect management

Doing so provides your body with two different pathways to maintain its antioxidant status